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esponsibility of InsAbstract Chitosan, a natural cationic polysaccharide, is prepared industrially by the hydrolysis of the
aminoacetyl groups of chitin, a naturally available marine polymer. Chitosan is a non-toxic,
biocompatible and biodegradable polymer and has attracted considerable interest in a wide range of
biomedical and pharmaceutical applications including drug delivery, cosmetics, and tissue engineering.
The primary hydroxyl and amine groups located on the backbone of chitosan are responsible for the
reactivity of the polymer and also act as sites for chemical modiﬁcation. However, chitosan has certain
limitations for use in controlled drug delivery and tissue engineering. These limitations can be overcome
by chemical modiﬁcation. Thus, modiﬁed chitosan hydrogels have gained importance in current research
on drug delivery and tissue engineering systems. This paper reviews the general properties of chitosan,
various methods of modiﬁcation, and applications of modiﬁed chitosan hydrogels.
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A hydrogel is a crosslinked network formed from a macro-
molecular hydrophilic polymer. It is stable upon swelling in
water and capable of absorbing a large amount of water,
varying from 10% to thousands of times of its own volume.
The physical properties, including swelling, permeation,
mechanical strength, and surface characteristics, can be
modulated through structural modiﬁcation. Hydrogels based
on natural polymers are currently receiving a great deal of
interest, and are notable for controlled delivery of bioactive
molecules and tissue engineering1–4.
Chitosan is a heteropolymer of glucosamine and N-acetyl
glucosamine residues (Fig. 1), and is obtained by deacetylation
of chitin5. It is a weak base, soluble in acidic solution
(pHo 6.5) and insoluble in water and organic solvents. It
forms a hydrogel in the presence of multi-valent anions, such
as tripolyphosphate (TPP) anions by ionic interaction between
the positively charged amino groups of chitosan and the
negatively charged counter-ion of TPP. Due to their hydro-
philic nature and greater solubility in acidic medium, chitosan
hydrogels exhibit relatively low mechanical strength and
limited ability to control the release of encapsulated com-
pounds5, thus necessitating chemical modiﬁcation facilitated
by its hydroxyl and amino groups.
Modiﬁed chitosan hydrogels have been proven to be a
potential carrier for delivery of different drug molecules with
respect to size and type6–8. As few reports were found on
modiﬁed chitosan hydrogel, this review summarizes recent
developments in its properties and applications.2. General properties of chitosan
Chitosan is commercially obtained by hydrolysis of the
aminoacetyl group of chitin, a straight chain homopolymer
composed of b-(1,4)-2-acetamido-2-deoxy-D-glucose units9.
Chitosan has one primary amino and two free hydroxyl
groups for each glucose unit. The cationic amino groups react
with a number of multi-valent anions to form hydrogels. In
physiological environments various enzymes, such as chitosa-
nase and lysozyme, degrade chitosan and form harmless
products. Increased deacetylation enhances the biocompat-
ibility of chitosan10. Entrapment of viable cartilage cells into
the chitosan hydrogel does not produce a signiﬁcant untoward
effect11 thereby improving the biocompatibility. Practical use
of unmodiﬁed chitosan has been limited due to its poor
solubility in acid solutions. Sugimoto et al.12 reported that
the water solubility of chitosan was improved by its modiﬁca-
tion with polyethylene glycol. Similarly, the properties of
chitosan, such as complexation, bacteriostatic effect,Figure 1 Chemical strabsorbability and antioxidant properties, have been shown
to be enhanced by its modiﬁcation13.3. Preparation of hydrogel by modiﬁcation of chitosan
Chitosan hydrogels have limited applications in drug delivery
and tissue engineering due to their hydrophilic nature and
insolubility in certain physiological conditions. Modiﬁcation
of the polymer can change the properties of the hydrogel.
Chitosan can be readily modiﬁed by reactions at the amino
groups and hydroxyl groups present in the molecule.
3.1. Modiﬁcation through covalent crosslinking
The physical properties of a hydrogel, such as crystallinity,
thermal sensitivity, swelling ratio, and mechanical strength,
can be improved by covalent crosslinking using glutaraldehyde
(GA), oxalic acid, formaldehyde, glyoxal, and genipine.
3.1.1. GA crosslinker
The covalent crosslinking of natural polymers can be achieved
through the reaction of their functional group with the
crosslinking agent GA (Scheme 1). A pH-sensitive GA-cross-
linked chitosan hydrogel system using acrylamide-grafted-poly
(vinyl alcohol) (PVA-g-AAm) and hydrolyzed PVA-g-AAm
has been prepared14. The release of drug is dependent on the
amount of GA in the matrix, i.e., on the extent of crosslinking.
For controlled release, hydrogel microspheres loaded with
5-ﬂuorouracil were prepared using chitosan and pluronic
F-127 crosslinked with GA15. The release of drug can be
extended up to 24 h by controlling the GA concentration. For
colonic delivery of 5-ﬂuorouracil, Lin et al.16 prepared
N-(2-carboxybenzyl) chitosan (CBCS)-based pH-sensitive
hydrogel (Scheme 2). The release of drug was pH dependent,
increasing with pH. It is assumed that the dominant carboxyl
groups (COOH) in the hydrogels would dissociate with the
increase of the osmotic pressure inside the hydrogel at higher
pH, resulting faster swelling and consequent release of drug.
Various polymers being used for the modiﬁcation of chitosan
hydrogel, crosslinked with GA are shown in Table 1.
3.1.2. Genipin crosslinker
Genipin, an aglycone derived from geniposide, is an excellent
natural crosslinker for proteins, collagen, gelatin and chitosan.
Beads of chitosan–alginate gel crosslinked by genipin have
been employed for drug delivery17. The IR spectroscopic data
indicates that the carboxymethyl group of genipin reacts with
amino group of chitosan, resulting the formation of a
secondary amide. The swelling of the prepared beads decreases
with the increase of pH. It is proposed that the protonateducture of chitosan.
Scheme 1 Covalently crosslinked chitosan hydrogel prepared using glutaraldehyde.
Scheme 2 Mechanistic pathway for the preparation of GA-crosslinked CBCS hydrogel16.
Table 1 Polymers used for modiﬁcation of chitosan hydrogels cross-linked with glutaraldehyde.
Polymer Change in property after modiﬁcation Application
Gelatin Increase in rigidity Carriers for caffeine in the human body17
Starch Flexibility and elasticity of the patch
improved with good bioadhesive properties
Controlled release delivery of a-hydroxy acid
contained in tamarind fruit pulp extract18
Hydroxyethyl cellulose Forms rigid network Controlled release delivery of chlorthiazide19
Polyethylene glycol Improves heparin blood compatibility and
anticoagulant property
Compatibility studies for various biomedical
applications20
Polyvinyl pyrrolidone Improves pH dependent swelling Controlled release system for amoxicillin delivery21
Poly(ethylene-graft-acrylamide) Forms rigid network Controlled release of capecitabine22
Poly(acrylic acid-co-acrylamide) Improves mechanical strength,
mucoadhesive force and solubility
Potential muco-adhesive systems for per oral delivery
of peptide and protein drugs23
Pluronic F127 Network structure becomes more rigid
resulting increased retention of drug
Controlled delivery of 5-ﬂurouracil15
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resulting the inhibition of nucleophilic attack on the dihydro-
pyran ring of genipin.
A novel sponge hydrogel of chitosan and silk crosslinked
by genipin has been prepared by Silva et al.18. It has been
observed that these sponge hydrogels promote adhesion,
proliferation, and matrix production of chondrocyte-like cells.
The investigators suggested that the genipin-crosslinked chit-
osan-silk ﬁbroin sponge hydrogels may be potential candidates
for cartilage tissue engineering. Polymers used for preparing
modiﬁed chitosan hydrogels crosslinked with genipin are
presented in Table 2.
3.1.3. N,N1-Methylenebisacrylamide (MBA) crosslinker
N,N1-Methylenebisacrylamide, a bifunctional monomer with
two identical unsaturated double bonds, is widely used as a
crosslinking agent in many ﬁelds. A novel heat- and pH-
sensitive hydrogel of carboxymethyl chitosan (CMCs) and poly
(N-isopropylacrylamide) crosslinked by MBA has beenreported19. The amount of co-enzyme A (Co A) released from
the MBA crosslinked hydrogel was relatively low (22.6%)
at pH 2.1, while at pH 7.4, the release of Co A increased
signiﬁcantly (89.1%) at 37 1C. Under the same conditions, the
swelling ratio has been found to increase with an increase of
pH. The speciﬁc hypothesis under study is that the release of Co
A from the hydrogel was hindered at pH 2.1 by large number of
H-bonds between the polar groups in Co A (–OH, –NH2, –
H2PO4, –SH and –NHCO) and the groups in the polymer
network. However, the phosphoric groups in Co A are
negatively charged at pH 7.4, and the electrostatic repulsion
between phosphoric salt and –COO facilitates the release of
Co A. It has also been observed that the release rate of Co A is
higher at 37 1C than that at 25 1C in buffer solution of pH 7.4.
Verapamil-loaded hydrogels, composed of chitosan and
acrylic acid, were prepared by free radical polymerization
using MBA as a crosslinking agent and benzoyl peroxide as a
catalyst4. The porosity and gel fraction of the beads increased
with the increasing MBA content. The release of verapamil
Table 2 Polymers used for modiﬁcation of chitosan hydrogels cross-linked with genipin.
Polymer Change in property after modiﬁcation Application
Alginate and N,O-
carboxymethy chitosan
Electrostatic repulsion between ionized acid groups
improves swelling property
Site speciﬁc protein delivery in the
intestine26
Carboxymethyl hexanoyl
chitosan
Degree of hexanoyl substitution changes the swelling ability
as well as solubility
Encapsulation of poorly water soluble
drug27
Carboxymethyl cellulose and
chitosan
Formation of polyion complex provides high strength and
stability
As a drug delivery carrier28
Chitosan and poly(vinyl
alcohol)
Modiﬁcation of chitosan content in the graft polymer
improves cell viability
Potential use in a variety of biomedical
application29
Chitosan and gelatin Rigidity of the matrix increased Biomedical application30
Chitosan and polyethylene
amide
Decrease in drug release rate with increase in crosslinking
density
Drug delivery application31
Chitin and chitosan Provides favorable environment for growth of cartilage cells Cultivation of bovine knee
chondrocyte32
Chitosan and gelatin Increase in porosity of the scaffolds Articular cartilage tissue engineering33
Tapan Kumar Giri et al.442depended on the ratio of chitosan to acrylic acid, the degree of
crosslinking, and pH of the medium. Another hydrogel was
synthesized by crosslinking an AAm–chitosan mixture (8:2, v/v)
with MBA for controlled delivery of amoxicillin20. The
hydrogel matrix released 56.47% and 77.096% of amoxicillin
after 24 h and 74 h, respectively.
3.2. Modiﬁcation through ionic crosslinking
The swelling behavior of the crosslinked chitosan hydrogel is
inﬂuenced by the ionization of functional groups along the
polymer chains and the ionization of crosslinking agent. For
controlled delivery of glipizide6, pH-sensitive hydrogel beads
of chitosan and TPP were prepared by ionic gelation. Both the
swelling ratio and drug release were directly related to the pH
of the dissolution medium.
Mucoadhesive hydrogel microparticles composed of poly
(methacrylic acid-vinyl pyrrolidone)–chitosan (PMVC) and
N-vinyl pyrrolidone (NVP) were prepared21 using the ionic
gelation method. Incorporation of NVP improved the release
of insulin from the hydrogel at acidic pH. NVP enhanced the
mucoadhesion behavior of hydrogel particles when studied in
rat intestine. Ionic crosslinking of chitosan and PEG to form
hydrogel beads using sodium TPP as crosslinking agent has
been reported22. A maximum loading efﬁciency of 90% was
obtained with 10% (w/v) TPP at pH 6.0 for 30 min. To
intestinally deliver a drug without losing drug in the stomach,
pH-sensitive chitosan hydrogel microspheres were prepared via
ionotropic crosslinking with sodium TPP and dextran sulfate23.
The release of drug from hydrogel microspheres was insignif-
icant in simulated gastric ﬂuid over 3 h, but nearly 100% of the
drug was released in simulated intestinal ﬂuid within 6 h.
pH-sensitive methotrexate chitosan-based microgels (o200 nm
diameter) were prepared by ionically crosslinking N-[(2-hydroxy-
3-trimethyl ammonium) propyl] chitosan chloride in the presence
of TPP24. It was observed that the crosslinked microgels exhibited
a signiﬁcant increase in cell motility of HeLa cells compared to
non-crosslinked microgels.
3.3. Modiﬁcation through grafting
Grafting of natural polymers such as chitosan containing
two types of reactive groups – amino and hydroxyl – is ofconsiderable interest for modiﬁcation of the polymer struc-
ture. Chemical grafting is initiated by generating one or more
free radicals on the chitosan chain and allowing these radicals
to react with polymerizable monomers that will constitute the
grafted chain.
AAm was grafted and polymerized onto chitosan by
Pourjavadi and Mahdavinia25 and the grafting was initiated
by ammonium persulfate (APS) under an inert atmosphere.
The graft polymer was hydrolyzed in hot sodium hydroxide
solution. The swelling capacity of both hydrolyzed and non-
hydrolyzed hydrogels increased with an increase in the AAm
concentration up to a certain limit, beyond which the swelling
capacity decreased. The non-hydrolyzed graft polymer showed
the maximum degree of swelling at pH 3 and hydrolyzed graft
polymer showed two maxima at pH 3 and 8. In acidic medium
(pH 3), the amino groups of chitosan become protonated and
the increased charge density and NH3
þ–NH3
þ electrostatic
repulsion enhanced the osmotic pressure inside the gel parti-
cles, resulting in further swelling. However, in basic conditions
(pH 8), the hydrolyzed graft polymer showed maximum
swelling due to ionization of carboxylic groups and the
electrostatic repulsive forces between the charged sites
(COO). Chen and Tan26 worked on graft copolymerization
of acrylic acid onto the chain of carboxymethyl chitosan and
subsequent crosslinking in aqueous medium by the same
radical system. The FTIR spectroscopic data conﬁrmed the
graft polymerization between acrylic acid and carboxymethyl
chitosan. The water absorption of the resultant graft polymer
was dependent on the crosslinking agent, initiator, monomer
concentration, reaction temperature, reaction time, degree of
neutralization of acrylic acid, and water volume of the system.
You et al.27 synthesized a graft copolymer of chitosan and
stearic acid by reacting the amine group of chitosan with the
carbonyl group of stearic acid. Nanoparticles prepared from
the graft copolymer loaded with paclitaxel effectively delivered
the drug into the cytoplasm of cancer cells. Superabsorbent
hydrogels were prepared by grafting chitosan with polyaniline
by an oxidative method28. It has been observed that the
crosslinking of the copolymers yielded a composite hydrogel in
which the polyaniline was homogeneously embedded.
A graft copolymer of sodium acrylate (AAs) and CMCs by
free radical polymerization using APS was prepared under a
nitrogen atmosphere and another graft copolymer of chitosan
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synthesized29. pH-sensitive hydrogel microspheres were pre-
pared by crosslinking carboxymethyl chitosan grafted with
acrylate (CMCs-g-AAs) and sodium alginate followed by
coating with chitosan grafted with poly (ethylene glycol)
(Cs-g-PEG) (Scheme 3).
In addition to the above chemical initiating system, various
radiation initiating systems have been tried for the synthesis of
chitosan-based graft copolymers. Since the radiation techni-
que is clean, safe and effective, it is a very convenient tool for
the modiﬁcation of natural polymers.
Cai et al.30 have prepared a graft copolymer of N-isopro-
pylacrylamide onto chitosan using 60Co g-radiation. Grafting
percentage and grafting efﬁciency were improved by increasing
the monomer concentration and radiation dose. The resultant
grafting hydrogels showed good heat and pH sensitivity with
good swelling property. El-Sherbiny and Smyth31 reported
photo-induced grafting of PEG onto to CMCS to confer pH
responsive drug delivery systems (Scheme 4). The grafting
percentage and grafting efﬁciency increased with increasing
concentration of the initiator within the range of 5.2–20.8 mM.
The optimum concentration was 10.4 mM.3.4. Modiﬁcation through polyelectrolyte complexes (PEC)
Chitosan is able to form polyelectrolyte complexes (PEC) with
various natural and synthetic anionic polyelectrolytes through
strong electrostatic interaction. The complex formation and
physical properties of the PEC depend on factors, such as theScheme 3 Proposed pathway for the synthesis of CMCs-g-AAs copol
of alginate/CMCs-g-AAs hydrogel microspheres coated with Cs-g-PEionization degree of the cationic and anionic counter parts,
pH, temperature, ionic strength, time of interaction and
concentration of the polymeric solutions32.
To modify the surface properties and to improve the
entrapment efﬁciency and release of drug, the calcium alginate
microparticles were coated with polycations such as chitosan,
poly-L-lysine and DEAE-dextran33. Coated microparticles
showed increased entrapment efﬁciency and slower release
of model protein drug. A polyion complex membrane was
prepared with chitosan and sodium alginate for the separation
of water and organic mixture34. The FTIR spectroscopy,
differential scanning calorimetry and thermogravimetric ana-
lysis indicated the formation of chitosan and sodium alginate
polyion complexes with ionic bonds between protonated
amine groups of chitosan and carboxylated groups of alginate.
Both ionic crosslinking and physical structure of hydrogel
inﬂuenced the state of water in ionic hydrogel membranes.
Polymer–magnetite hybrid nanoparticles were prepared
using polyion complex of carboxymethyl cellulose and chit-
osan as follows35: the carboxymethyl cellulose and chitosan
were blended to form polyion complexes (CC particles); the
CC particles were chemically crosslinked with genipin to
provide gel particles (CCG particles) with improved strength
and stability; ﬁnally, magnetite was synthesized within CCG
particles by the coprecipitation method to obtain polymer–
magnetite hybrid nanoparticles (CCGM). The synthetic route
for the formation of CCGM particles are shown in Scheme 5.
Chitosan has also been used for the preparation of various
polyelectrolyte complex products with natural and synthetic
polyions such as xanthan, hyaluronic acid, alginate, collagen,ymer (A), synthesis of Cs-g-PEG copolymer (B), and development
G (C)44.
Scheme 4 Proposed pathway for the preparation of CMCs-g-PEG copolymer and its hydrogel matrix46.
Scheme 5 Proposed synthetic route for the formation of CCGM particles28.
Tapan Kumar Giri et al.444gum kondagogu, pectin, carrageenen, gelatin, dextransulfate,
Y-glutamic acid, carboxymethylcellulose, Eudragit S100 and
polyalkyleneoxide-maleic acid copolymer.4. Applications
4.1. Drug delivery application
Since chitosan is positively charged, it can interact with
negatively charged polymers, macromolecules and polyions.Chitosan-based hydrogel systems can be used for oral,
transdermal, nasal, rectal and ocular drug delivery.4.1.1. Oral drug delivery
Oral delivery is widely accepted for drug administration.
Chitosan-based hydrogels have been investigated in a number
of therapeutic oral delivery systems either as controlled release
matrices or functional biomaterials. Chitosan-based hydrogel
has been used for the delivery of drugs to speciﬁc sites of the
body such as oral cavity, stomach, small intestine and colon.
The site-speciﬁc delivery of the drug to the oral cavity can be
Modiﬁed chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications 445used to treat a number of diseases of the mouth, such as
stomatitis, periodontal disease, fungal and viral infections, and
oral cavity cancers, thereby avoiding the ﬁrst pass metabolism
effect. Chlorhexidine buccal tablets were prepared using drug-
loaded chitosan microparticles by a spray-drying technique36.
The antimicrobial activity of the drug against Candida albicans
was improved. Moreover, an in vivo study showed that the
formulation exhibited a prolonged release of the drug in the
buccal cavity. Antibacterial activity of chitosan-based thermo-
sensitive hydrogel was effective against the periodontal patho-
gens-Porphyromonas gingivalis, Prevotella internedia and
Actenobacillus actinomycetem comitans37. Experimental results
demonstrated that the thermosensitive hydrogel acts as the
vehicle as well as an activator for the antibacterial process.
Chitosan based hydrogel systems can be designed to deliver
drugs locally to the stomach or the upper part of GIT to
improve bioavailability. Chang et al.38 developed amoxicillin-
loaded pH-sensitive hydrogels composed of chitosan and
poly(g-glutamic acid) for the treatment of Helicobacter pylori
(H. pylori) infection in the peptic ulcer disease. A confocal
laser scanning microscopic study indicated that the hydrogels
could inﬁltrate the cell–cell junctions and interact with
H. pylori infection sites in the intercellular spaces. Hydrogel
of chitosan and polyacrylic acids containing amoxicillin and
clarithromycin were also clinically evaluated for H. pylori
eradication39. Clinical trial experiments indicated that the
polyionic hydrogel could serve as suitable candidates for
amoxicillin and clarithromycin site-speciﬁc delivery in the
stomach. Modiﬁed chitosan hydrogels loaded with metroni-
dazole, tetracycline and theophylline were developed for
stomach-speciﬁc delivery. Modiﬁed chitosan hydrogels can
bypass the acidic environment of the stomach and release the
loaded drug into the intestine.
A novel pH-sensitive composite hydrogel of chitosan-graft-
poly (acrylic acid), attapulgite, and sodium alginate was
developed for controlled release of diclofenac sodium (DS)40.
The cumulative release rate of DS from the composite
hydrogel beads was insigniﬁcant at pH 2.1 and 100% at pH
6.8 within 24 h. However, most of the loaded DS was released
within 2 h at pH 7.4. A novel pH-sensitive hydrogel bead
composed of N-succinyl chitosan and alginate was developed
by Dai et al.41 using nifedine. The in vitro release of nifedipine
from the hydrogel bead was 11.6% at pH 1.5 while 76% at pH
7.4. Superporous hydrogel based on poly(acrylic acid-co-
AAm) and N,O-CMCs was prepared for the oral delivery of
insulin42. In vivo results showed that the oral administration of
insulin-loaded hydrogel yielded notable insulin absorption and
a hypoglycemic effect. Moreover, the biocompatibility of the
hydrogel was conﬁrmed by an oral acute and sub-acute
toxicity study in mice. Similarly, superporous hydrogels were
prepared and evaluated for their potential in effective insulin
absorption via the oral route43.
Another novel temperature- and pH-sensitive hydrogel
based on chitosan grafted with poly(acrylic acid), poly(hy-
droxy propyl methacrylate), poly(vinyl alcohol) and gelatin
was prepared for controlled drug delivery of oxytetracycline44.
It was observed that the release of the drug increased with the
increasing time, temperature and pH and reached to the
maximum after 48 h at pH 9.
A pH-sensitive hydrogel using CMCs and alginate was also
prepared by crosslinking with genipin for site-speciﬁc protein
drug delivery in the intestine45. The release of BSA at pH 1.2was relatively low, but increased signiﬁcantly at pH 7.4. It may
be due to the formation of hydrogen bonds between CMCs
and alginate at pH 1.2 that restricts the swelling. At pH 7.4,
the hydrogel swelled more signiﬁcantly due to large swelling
force created by electrostatic repulsion between the ionized
acid groups.
Colon speciﬁc drug delivery systems are gaining importance
for use in the treatment of chronic diseases, such as irritable
bowel syndrome, inﬂammatory bowel disease, ulcerative coli-
tis, and also for the systemic delivery of protein and peptide
drugs. Xu et al.46 prepared dual crosslinked gel beads
composed of alginate and chitosan for the colonic site-speciﬁc
delivery of bovine serum albumin (BSA). The release of BSA
from all beads was much faster in simulated colonic ﬂuid than
in simulated intestinal ﬂuid. Chitosan hydrogel beads were
prepared by the crosslinking method followed by enteric
coating with Eudragit S100 for targeted delivery of Satrani-
dazole to the colon47. The chitosan beads prevented premature
drug release in simulated gastric ﬂuid. However, most of the
loaded drugs were released in the colon, an environment rich
in bacterial enzymes that degrade chitosan. Several chitosan-
based formulations are being investigated as carriers for
colon-speciﬁc delivery of 5-aminosalicyclic acid, prednisolone,
metronidazole, 5-ﬂuorouracil and indomethacin.
4.1.2. Transdermal drug delivery
Transdermal drug delivery systems in the form of hydrogel
membranes can deliver drugs for systemic effects through skin
at a predetermined and controlled rate. This system presents the
advantage of avoiding the ﬁrst pass metabolism effect. Drug
delivery can be easily interrupted on demand by simply
removing the devices. The hydrogel patch composed of chitosan
and starch crosslinked with GA has been prepared for con-
trolled release of a-hydroxy acid contained in tamarind fruit
pulp extract48. The resultant patches showed good bio-adhesive
properties and the amount of tartaric acid released was
proportional to the square root of time (Higuchi’s model49,50).
Similarly, a curcuminoid-loaded hydrogel patch composed
of chitosan and starch was developed for cosmetic applica-
tions51. A rapid rate of curcumin release was observed by the
vertical diffusion cell method. A transdermal delivery system
for the treatment of cutaneous leishmaniasis was developed
by incorporating berberine into a chitosan hydrogel52. The
in vitro skin perfusion studies indicated that only trace
amounts of berberine permeated through the rat skin due to
its low oil–water partition coefﬁcient. Surfactants can enhance
percutaneous absorption of berberine.
Novel lidocaine hydrochloride-loaded transdermal chitosan
patches were developed using a chitosan membrane for rate
control and a chitosan hydrogel as a drug reservoir53. In vitro
drug release was prolonged by chitosan having a 95% degree
of deacetylation.
4.1.3. Ocular drug delivery
The major problem with conventional eye drops is retention in
the eye. The administration of ophthalmic drugs in hydrogels
has been shown to increase the contact time of the drugs with
cornea, thereby increasing ocular bioavailability. An in situ
thermosensitive hydrogel composed of chitosan and b-glycer-
ophosphate (GP) was prepared54. The hydrogel enhanced the
transcorneal permeation to 7-fold over an aqueous solution,
improved ocular bioavailability, minimized the need for
Tapan Kumar Giri et al.446frequent administration and decreased the ocular side effects
of oﬂoxacin. Another in situ thermosensitive hydrogel com-
posed of chitosan and poly (N-isolpropylacrylamide) was
prepared for ocular delivery of timolol maleate55. The drug
release from the hydrogel was also doubled.
To increase its ocular bioavailability, Genta et al.56 prepared
bioadhesive chitosan microspheres for ophthalmic administra-
tion of acyclovir. In vivo ocular studies on rabbits indicated a
high concentration of acyclovir for an extended period of time.
4.1.4. Nasal drug delivery
The nasal mucosal membrane presents a potentially useful site
for the delivery of drugs by combining a decreased ﬁrst pass
effect with greater patient acceptability. Chitosan hydrogels
improve nasal absorption of drugs since they facilitate the
paracellular transport of large molecules across the mucosal
surface by opening tight junctions. Nazar et al.57 synthesized
N-trimethyl chitosan chloride and formulated it into a hydrogel
with PEG and GP for nasal drug delivery. The hydrogel
containing N-trimethyl chitosan with medium average molecu-
lar weight and a low degree of quaternization yielded an
aqueous formulation that exhibits a sol–gel transition at
32.5 1C within 7 min. A thermosensitive in situ gel system was
prepared by mixing chitosan and polyvinyl alcohol for the nasal
delivery of insulin58. The prepared hydrogel exhibited a sol-gel
transition at 37 1C for approximately 12 min. The release of
insulin maintained steady blood glucose levels for 6 h.
Alsarra et al.59 evaluated different polymeric hydrogels,
such as polyvinyl pyrrolidone (PVP), chitosan and carbopol,
for the nasal delivery of acyclovir. The release rates of
acyclovir from PVP gels were higher compared to chitosan
or carbopol gels. A histopathological study indicated that the
PVP was a safe hydrogel for mucosal delivery.
A novel thermosensitive hydrogel system was prepared by
simply mixing quaternized chitosan and PEG with a small amount
of a-b-GP for nasal drug delivery60. The in vivo study showed that
the prepared hydrogel decreased the blood glucose concentration
(40–50% of initial blood glucose concentration) after 4–5 h of
administration. Spray-dried microspheres based on methylpyrro-
lidinone chitosan were developed for nasal administration of
metoclopromide61. The in vitro and in vivo study indicated that
the microspheres could be a suitable nasal delivery system for
the administration of metoclopramide.
4.1.5. Rectal drug delivery
The rectum has been studied as a favorable site of drug
delivery for local and systemic action. This route offers certain
advantages with local targeting of drugs to the organs. It may
also represent an alternative to intravenous or other injection
routes of drug administration. The DS-loaded chitosan micro-
spheres were incorporated into hydrogels containing hydro-
xypropyl methylcellulose (HPMC) and carbopol 934 for rectal
administration62. The viscosity of rectal hydrogels inﬂuences
the drug release and distribution of hydrogels in the distal
portion of the large intestine.
4.2. Tissue engineering applications
Tissue and organ loss or damage is a major human health
problem. Transplantation of tissue or organs is a standard therapy
to treat these patients. However, this therapy is severely limiteddue to the shortage of donors. Tissue engineering (TE) is one of
the available therapies to treat the loss or damaged tissue and
organ. It involves in vitro seeding and attachment of human cells
onto a scaffold, followed by the culturing of the cells to form the
new organ or tissue. Chitosan is a promising polymer for tissue
engineering for its non-toxicity, biocompatibility and biodegrad-
ability. Moreover, chitosan has structural similarity to glucosa-
minoglycans which are the major component of the extracellular
matrix.
Ladet et al.63 developed a chitosan-based multi-membrane
hydrogel (MMH) to investigate the in vitro responsiveness of
articular chondrocyte-like cells. The cells aggregated, prolifer-
ated and maintained their phenotype with the production of a
large amount of cartilage-type matrix proteins.
An insulin-loaded, glucose-sensitive hydrogel composed of
N-succinyl chitosan (SCS) and aldehyde hyaluronic acid
covalently conjugated with glucose oxidase (GOD) and cata-
lase was developed for adipose tissue regeneration64. The
GOD converts glucose to gluconic acid in the presence of
glucose. The gluconic acid reduced the pH value of the
microenvironment which triggered the swelling of the pH-
sensitive hydrogel and consequently facilitated the release of
insulin by a diffusion-mediated process.
Tran et al.65 prepared an in situ forming rutin-releasing
chitosan hydrogel as an injectable dressing for wound healing.
An in vivo wound-healing study on rat dorsal wounds demon-
strated that rutin-conjugated hydrogel exhibited improved
wound healing as compared with the hydrogel without rutin.
Yang et al.66 prepared a series of hydrogels from an
aqueous solution of gelatin and carboxymethyl chitosan by
radiation-induced crosslinking at ambient temperature for
wound healing. The obtained hydrogels promoted cell attach-
ment and rapid growth of ﬁbroblast on the materials.
A novel injectable scaffold was developed by combining
collagen-coated poly-lactide microcarriers and a crosslinkable
chitosan hydrogel loaded with cartilage tissue of rabbit ear for
cartilage regeneration67. A novel thermosensitive hydrogel
composed of chitosan and pluronic was developed as an
injectable cell delivery carrier for cartilage regeneration68.
Despite the enormous progress of bone tissue engineering, there
are still a number of barriers for the treatment of bone injuries.
Luca et al.69 studied the effects of carrier and pH on recombinant
human BMP-2 (rhBMP-2) induced non-osseous bone formation.
They observed that the injection of rhBMP-2 in a chitosan
hydrogel induced bone formation in the muscle of rats.
In another study, an injectable thermosensitive hydrogel
composed of chitosan and PVA was developed for bone tissue
engineering70. It was observed that the rabbit bone marrow
mesenchymal stem cells proliferated in the hydrogel within
3 weeks.
Tang et al.71 prepared injectable hydrogels composed of
chitosan and methyl cellulose that were liquid at low tem-
perature (about 4 1C) and gel under physiologic conditions
(37 1C) for cartilage tissue regeneration. The obtained hydro-
gel resulted in good cell viability and proliferation.
A set of novel injectable hydrogels composed of chitosan
derivative, polyethylene glycol dimethacrylate and N,N-dimethyl-
acrylamide was prepared for bone tissue regeneration72.
The resultant hydrogels were promoted cell attachment and
proliferation.
Severe hepatic failure accounts for many deaths each year
worldwide. Liver transplantation is limited due to the shortage
Modiﬁed chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications 447of available organ donors. Therefore, liver tissue engineering is
a potential approach to provide liver tissue for patients
suffering from hepatic failure. Yang et al.73 developed porous
polymer scaffolds composed of alginate and galactosylated
chitosan (GC) for liver tissue engineering. The resultant
scaffolds were suitable for improving hepatocyte adhesion
and maintenance of cell viability.
Most neurons in the central nervous system (CNS) do not
proliferate or renew themselves. Therefore, interest has
focused upon cell replacement therapies to repair damage in
the CNS. Thermally responsive hydrogels composed of chit-
osan and GP were prepared for neural tissue regeneration74. A
photo-crosslinkable hydrogel based on chitosan was synthe-
sized by conjugating 4-azidobenzoic acid with chitosan
and crosslinked by UV illumination for peripheral nerve
anastomosis75.
New blood vessel formation is a promising alternative to
treat patients suffering from restricted or obstructed blood
ﬂow caused by coronary and peripheral arterial disease.
Mathews et al.76 investigated the attachment and growth of
bovine aortic endothelial cell (BAEC) and smooth muscle cells
(BASMC) on PVA hydrogels modiﬁed with water-soluble and
water-insoluble chitosan. A cell adhesion study indicated that
BAEC and BASMC successfully adhered to the PVA–chitosan
membranes.5. Conclusions
This review summarizes the potential applications of modiﬁed
chitosan hydrogel for biomedical and pharmaceutical uses,
particularly with regard to drug delivery, in vitro cell culture,
and tissue engineering. The most attractive feature of chitosan
for these applications is biocompatibility, as well as ease of
preparing derivatives with new properties. Modiﬁed chitosan
hydrogels have great utility in developing controlled-release
formulations of almost all types of bioactive molecules.
Recently, modiﬁed chitosan hydrogels have been extensively
explored for tissue engineering applications, e.g., cell trans-
plantation and tissue regeneration. It can be concluded that
for tissue engineering and drug delivery chitosan-based hydro-
gels are expected to become a promising matrix for use in
regenerative medicine and drug delivery.
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